Johnson and Johnson's Covid-19 vaccine approval possible in March
Emergency Use Approval for Johnson&Johnson's Covid-19 vaccine may not arrive before March, potentially a few weeks later than had been hoped for.
However, the first batch of late-stage clinical trial data is expected in the last week of January or the first week of February, the drug giant's Chief Scientific Officer, Paul Stoffels, told Bloomberg in an interview.
Officials from the US government's Operation Warp Speed are on record predicting that EUA might arrive in the middle of February, but that timeline might prove to aggressive given J&J's own guidance, the newswire added.
Stoffels reportedly added: "We hope and trust that somewhere in March, we may get that approval."
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.